DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 25, 2020

Primary Completion Date

October 21, 2022

Study Completion Date

October 21, 2022

Conditions
Chronic Lymphocytic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositivePlasma Cell Myeloma
Interventions
BEHAVIORAL

The DISCO App

Patients will receive an individually-tailorable cancer treatment cost education and communication intervention delivered on an iPad just prior to meeting with their oncologist.

BEHAVIORAL

Usual Care

Patients randomized to this arm will receive usual care.

Trial Locations (1)

48201

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT04282343 - DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter